K.J. Harrison & Partners Inc Grows Position in Zimmer Biomet Holdings, Inc. (ZBH)

K.J. Harrison & Partners Inc raised its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 28.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,000 shares of the medical equipment provider’s stock after acquiring an additional 2,000 shares during the period. K.J. Harrison & Partners Inc’s holdings in Zimmer Biomet Holdings were worth $1,054,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Enterprise Financial Services Corp raised its holdings in Zimmer Biomet Holdings by 0.3% in the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after acquiring an additional 9 shares in the last quarter. Cleararc Capital Inc. raised its holdings in Zimmer Biomet Holdings by 0.5% in the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after acquiring an additional 25 shares in the last quarter. Parkside Financial Bank & Trust raised its holdings in Zimmer Biomet Holdings by 3.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after acquiring an additional 33 shares in the last quarter. CWA Asset Management Group LLC raised its holdings in Zimmer Biomet Holdings by 1.8% in the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after acquiring an additional 34 shares in the last quarter. Finally, Advisory Services Network LLC raised its holdings in Zimmer Biomet Holdings by 1.0% in the 2nd quarter. Advisory Services Network LLC now owns 3,690 shares of the medical equipment provider’s stock valued at $474,000 after acquiring an additional 37 shares in the last quarter. 85.26% of the stock is owned by hedge funds and other institutional investors.

Shares of Zimmer Biomet Holdings, Inc. (ZBH) traded up 0.27% during midday trading on Tuesday, hitting $121.68. The company had a trading volume of 559,211 shares. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49. The firm’s 50 day moving average is $118.15 and its 200 day moving average is $120.46. The company has a market capitalization of $24.60 billion, a P/E ratio of 34.66 and a beta of 1.19.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 22nd were given a dividend of $0.24 per share. The ex-dividend date was Thursday, September 21st. This represents a $0.96 annualized dividend and a yield of 0.79%. Zimmer Biomet Holdings’s payout ratio is 27.59%.

ILLEGAL ACTIVITY WARNING: This article was posted by Community Financial News and is owned by of Community Financial News. If you are reading this article on another site, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this article can be viewed at https://www.com-unik.info/2017/10/31/k-j-harrison-partners-inc-grows-position-in-zimmer-biomet-holdings-inc-zbh.html.

ZBH has been the subject of several analyst reports. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. BMO Capital Markets reaffirmed a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Guggenheim raised Zimmer Biomet Holdings from a “neutral” rating to a “buy” rating and set a $157.00 price objective for the company in a report on Wednesday, July 12th. Needham & Company LLC reaffirmed a “strong-buy” rating and issued a $153.00 price objective on shares of Zimmer Biomet Holdings in a report on Wednesday, July 12th. Finally, Canaccord Genuity reaffirmed a “buy” rating and issued a $141.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $136.55.

Zimmer Biomet Holdings Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

What are top analysts saying about Zimmer Biomet Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Zimmer Biomet Holdings Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit